The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

Tuberculosis remains the world's leading infectious killer, resulting in more than 1·25 million deaths in 2023 alone.1 During ...

New drugs that target "zombie" tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

Home Health under the radar Tuberculosis sees a resurgence and is only going to get worse The spread of the deadly infection is buoyed by global unrest ...

When health workers stopped visiting her home in Pakistan to administer tuberculosis medication, Ratna Jamni began dragging herself to a clinic “step by painful step, when even standing feels ...

Many strains of tuberculosis are already resistant to the 60-year-old drugs that are still the first line of treatment for nearly all TB patients.

Tuberculosis (TB) is the world’s biggest infectious disease killer with multidrug-resistant TB (MDR-TB) posing a particular threat to global health. A study led by the Swiss Tropical and ...

The WHO Global Tuberculosis Report 2024 says TB remains a leading cause of death in Nigeria. The prevalence of drug-resistant TB and the overlap with HIV exacerbate the problem, presenting new ...

Tuberculosis (TB) medication can cause short-term side effects, such as loss of appetite, fever, and fatigue. Long-term side effects can include lung dysfunction and issues with the digestive system.

Analysis of finger sweat detected isoniazid in adults with tuberculosis (TB) for ≤ 6 hours after administration, based on data from a new pilot study. Risk factors for TB treatment failure ...

The Coordinating Minister of Health and Social Welfare, Prof Muhammad Pate, has said that a national drug-resistant survey on Tuberculosis will be conducted this year to determine the actual ...